Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Natco Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524816NSE Symbol: NATCOPHARMP/E(TTM):9.44
ISIN Demat:INE987B01026Div & Yield %:0.68EPS(TTM):93.7
Book Value(Rs):409.4649822Market Cap ( Cr.):15838.69Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 4094.503568.902351.001767.801653.501790.20
Excise Duty0.000.000.000.000.000.00
Net Sales4094.503568.902351.001767.801653.501790.20
Other Income 321.30104.7085.5094.60101.10123.80
Stock Adjustments -11.60-17.20-34.605.5046.9055.90
Total Income4404.203656.402401.901867.901801.501969.90
EXPENDITURE :      
Raw Materials 581.70557.30495.10540.10546.90452.90
Power & Fuel Cost93.1088.9081.9076.4059.4062.40
Employee Cost 515.30454.90425.70410.10380.00356.10
Other Manufacturing Expenses 217.70179.80150.30148.70114.30134.70
Selling and Administration Expenses 444.10483.70290.70309.10140.30202.30
Miscellaneous Expenses 86.70150.1028.0075.9041.9059.70
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1938.601914.701471.701560.301282.801268.10
Operating Profit2465.601741.70930.20307.60518.70701.80
Interest 19.6014.508.6013.3011.3020.60
Gross Profit2446.001727.20921.60294.30507.40681.20
Depreciation220.00171.90150.90138.40115.2098.10
Profit Before Tax2226.001555.30770.70155.90392.20583.10
Tax407.50284.80133.1032.5093.30129.10
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-31.90-36.100.50-15.70-10.60-20.50
Reported Net Profit1850.401306.60637.10139.10309.50474.50
Extraordinary Items 72.22-2.1214.7133.8024.3912.69
Adjusted Net Profit1778.181308.72622.39105.30285.11461.81
Adjst. below Net Profit 3.00-44.70-1.000.402.20-31.40
P & L Balance brought forward4226.303134.602587.102520.502322.502006.80
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 107.50170.2088.6072.90113.90127.40
P & L Balance carried down5972.204226.303134.602587.102520.302322.50
Dividend0.00170.20100.4082.10113.90127.40
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %300.00475.00275.00225.00262.50337.50
Earnings Per Share-Unit Curr103.3772.9934.917.6216.9626.07
Earnings Per Share(Adj)-Unit Curr103.3772.9934.917.6216.9626.07
Book Value-Unit Curr409.72312.42257.64229.69224.17212.61